ArticleChina CDC weekly2020
HIV and HCV Infection Status Among Drug Users - China, 2010-2018.
Article in China CDC weekly, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed, 6 citations in OpenAlex.
- Pay-it-forward incentives for hepatitis virus testing in men who have sex with men: a cluster randomized trial.Nature medicine · 2023Trial
- Baseline spouse testing in newly diagnosed people living with human immunodeficiency virus in China from 2011 to 2020: a nationwide, retrospective study.BMC infectious diseases · 2025Article
- HBV and HCV Co-Infection in Chinese Newly Diagnosed HIV+ Subjects in 2015 and 2023: A Cross-Sectional Study.Pathogens (Basel, Switzerland) · 2024Article
- Modeling the Impacts of Prevention and Treatment Interventions on Hepatitis C Among People Who Inject Drugs in China.Infectious diseases and therapy · 2023Article
- Epidemiological Characteristics of Newly Diagnosed Cases of HIV through Injection Drug Use - China, 2012-2019.China CDC weekly · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
It is known that drug users (DUs) was brought into human immunodeficiency virus (HIV) sentinel surveillance as HIV related high-risk group since 1990s with a higher HIV antibody positive rate in the early stage. This study not only showed that HIV antibody positive rate had decreased steadily since 2010 and maintained stable in past 4 years, but also showed that the proportion of the new narcotic and the mixed drug users increased since 2010 and HIV antibody positive rate of mixed abuse users increased year by year. Some existing policies and strategies publicity, education and interventions require adjustments since new narcotic drug users contributed to DUs HIV infections. The challenge of HIV infection and transmission among drug users abusing both traditional and new narcotic drugs also require more attention.
Identifiers
34594835PMC8428419W3022620123What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.